Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cardiol Therapeutics Inc. (CRDL) vs Organogenesis (ORGO)

Cardiol Therapeutics Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. and Organogenesis are of similar size ($207.1M and $202.1M). Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −22.2%) and the higher return on invested capital (0.00% vs −20.0%). Across the 15 metrics below, Organogenesis leads on 9 and Cardiol Therapeutics Inc. on 6.

Valuation

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 0.39 2.25
P/B 11.32 1.22 1.90
Price to free cash flow n/m 8.64 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.33 2.56
Earnings yield (14.62%) (60.71%) (2.99%)
Free cash flow yield (8.77%) 11.57% 0.00%

Profitability

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 70.35% 53.94%
Operating margin 0.00% (7.84%) 0.00%
Net margin 0.00% (22.23%) 0.00%
Free cash flow margin 0.00% 4.56% 0.00%
Return on equity (171.13%) (53.31%) (0.40%)
Return on assets (124.40%) (23.44%) (3.32%)
Return on invested capital 0.00% (19.97%) 0.00%

Growth

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 6.50% 10.01%
EPS growth (last fiscal year) 24.32% 1,600.00% —
Revenue growth, 5-year CAGR — 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.07 0.05
Current ratio 5.55 3.52 2.31
Net debt to EBITDA 0.62 (1.14) 0.85

Dividend

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Market cap 202.10m 207.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack